Dibucaine Hcl 0.5% / Lidocaine 15% / Phenylephrine Hcl 1% / Prilocaine 5%
FDA Label NDC 72934-5071

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sincerus Florida, Llc for the product Dibucaine Hcl 0.5% / Lidocaine 15% / Phenylephrine Hcl 1% / Prilocaine 5% (NDC 72934-5071). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions for use, sincerus florida, llc. adverse reactions, active, inactive, ndc 72934-5071-3 dibucaine hcl usp 0.5% / lidocaine usp 15% / phenylephrine hcl usp 1% / prilocaine usp 5%. ointment 120gm, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.